These exchanges are a fine swansong to our collective efforts to understand the science, the various management teams and the competition (;-). Lilly's bid for the company has reduced the havoc to my stock portfolio; the capital gains reeper looms. Cheers to one and all, hoping for recoveries of many sorts in '09. R, LLH